The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma. Read More >>
lymphoma
June 3, 2022 · Greg Guthrie, ASCO staff
February 3, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Christopher Flowers discusses research from the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition, including studies evaluating new treatments for diffuse large B-cell lymphoma and an overview of a session on improving equity in cancer clinical trials. Read More >>
June 17, 2021 · Craig A. Portell, MD
Dr. Craig A. Portell discusses what CAR T-cell therapy is, how it works, what its common side effects are, and how it’s changing the landscape of how some types of cancers are treated. Read More >>
March 30, 2021 · ASCO Staff
Be The Match, the national bone marrow transplant registry, needs people of different racial and ethnic backgrounds to volunteer as donors. Learn why having diversity in the registry is important, what disparities exist, and how to sign up. Read More >>
January 15, 2021 · Brielle Gregory, ASCO staff
In this podcast, Dr. Michael Williams discusses studies and a report on the treatment of leukemia and lymphoma presented at last month’s ASH Annual Meeting. Read More >>
Pages
- first page
- previous page
- page 1
- 2 current page
- page 3
- page 4
- page 5
- next page
- last page